Cytosorbents Corporation (CTSO) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Earnings Reports
-
Cytosorbents (CTSO) Q1 2026: Direct International Grows 13% as U.S. Regulatory Path Clarifies
May 14, 2026
-
Cytosorbents (CTSO) Q4 2025: International Sales Rise 13% as Germany Restructuring Nears Completion
March 26, 2026
-
CytoSorbents (CTSO) Q3 2025: Cost Actions Target Q1 Breakeven as Gross Margin Hits 70%
November 14, 2025
-
CTSO Q2 2025: German Sales Jump 22% as Regulatory Appeals Shape Near-Term Trajectory
August 08, 2025